Personal Approach to Treatment Choices for HIV (PATCH): Randomized Controlled Trial of a Brief Motivational Enhancement Intervention to Improve Medication Adherence in Persons with HIV

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2019 Dec 16

PMID 31838589

Citations 3

Authors

Jacob Scharer

Rachel Arnold

Rebecca Wald

Jamie Nichols

Deborah Medoff

Seth Himelhoch

Melanie E Bennett

Affiliations

Soon will be listed here.

Abstract

This pilot randomized controlled trial evaluated the feasibility and efficacy of a brief motivational enhancement intervention to improve adherence to antiretroviral therapy in persons with HIV called Personal Approach to Treatment Choices for HIV (PATCH). We compared PATCH to an active control condition on self-reported adherence, clinical outcomes, and psychosocial outcomes. Participants were 34 individuals (61.8% male, M = 47.1) receiving HIV-related services who were suboptimally engaged in care. Participants completed baseline measures, participated in either PATCH or a stress reduction skills control intervention, and completed post-treatment and 3-month follow-up assessments. Results revealed no differences between conditions on adherence or clinical outcomes. At post-treatment, PATCH participants reported greater improvements in alcohol use, psychiatric symptoms, subjective mental functioning, and emotion-focused coping; improvements in subjective mental functioning were maintained at 3-months. Results suggest that motivational enhancement interventions can improve psychosocial outcomes for people with HIV. That some improvements were not maintained at follow-up suggests that effects wane over time and longer treatment may be indicated for lasting effects.

Citing Articles

Prevalence and Individualized Risk Factors of and Infections Among People Living with HIV (PLHIV) with Diarrhea in Ecuador: Insights from a Single-Center Cross-Sectional Study.

Pazmino-Gomez B, Rodas-Pazmino J, Guevara-Viejo F, Rodas-Pazmino K, Coello-Peralta R, Rodas-Neira E J Clin Med. 2025; 14(2).

PMID: 39860354 PMC: 11766262. DOI: 10.3390/jcm14020348.

Does the Quality of Behavior Change Counseling in Routine HIV Care Vary According to Topic and Demand?.

Claus L, Laws M, Wilson I, Han D, Saha S, Moore R AIDS Behav. 2023; 27(11):3780-3788.

PMID: 37792233 DOI: 10.1007/s10461-023-04135-8.

"The role of case management in HIV treatment adherence: HPTN 078".

Tolley E, Hamilton E, Eley N, Maragh-Bass A, Okumu E, Balan I AIDS Behav. 2022; 26(9):3119-3130.

PMID: 35362913 PMC: 9371990. DOI: 10.1007/s10461-022-03644-2.

Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials.

Ghizzardi G, Arrigoni C, Dellafiore F, Vellone E, Caruso R Heart Fail Rev. 2021; 27(4):1029-1041.

PMID: 33866487 DOI: 10.1007/s10741-021-10110-z.

References

Boussari O, Subtil F, Genolini C, Bastard M, Iwaz J, Fonton N . Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality. BMC Med Res Methodol. 2015; 15:10. PMC: 4429708. DOI: 10.1186/1471-2288-15-10. View

Chesney M, Morin M, Sherr L . Adherence to HIV combination therapy. Soc Sci Med. 2000; 50(11):1599-605. DOI: 10.1016/s0277-9536(99)00468-2. View

Mannheimer S, Matts J, Telzak E, Chesney M, Child C, Wu A . Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005; 17(1):10-22. DOI: 10.1080/09540120412331305098. View

Bangsberg D, Mills E . Long-term adherence to antiretroviral therapy in resource-limited settings: a bitter pill to swallow. Antivir Ther. 2013; 18(1):25-8. DOI: 10.3851/IMP2536. View

Simoni J, Huh D, Wilson I, Shen J, Goggin K, Reynolds N . Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012; 60(5):466-72. PMC: 3607367. DOI: 10.1097/QAI.0b013e31825db0bd. View

Armstrong K, McMurphy S, Dean L, Micco E, Putt M, Halbert C . Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008; 23(6):827-33. PMC: 2517897. DOI: 10.1007/s11606-008-0561-9. View

Egger M, May M, Chene G, Phillips A, Ledergerber B, Dabis F . Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360(9327):119-29. DOI: 10.1016/s0140-6736(02)09411-4. View

Pradier C, Bentz L, Spire B, Tourette-Turgis C, Morin M, Souville M . Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003; 4(2):121-31. DOI: 10.1310/brbv-3941-h1pp-ndry. View

DeRogatis L, Melisaratos N . The Brief Symptom Inventory: an introductory report. Psychol Med. 1983; 13(3):595-605. View

10.

Malta M, Magnanini M, Strathdee S, Bastos F . Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2008; 14(4):731-47. DOI: 10.1007/s10461-008-9489-7. View

11.

Mannheimer S, Friedland G, Matts J, Child C, Chesney M . The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002; 34(8):1115-21. DOI: 10.1086/339074. View

12.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J . Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther. 2004; 9(3):407-14. View

13.

Feingold A . Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis. Psychol Methods. 2009; 14(1):43-53. PMC: 2712654. DOI: 10.1037/a0014699. View

14.

Ulett K, Willig J, Lin H, Routman J, Abroms S, Allison J . The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2008; 23(1):41-9. PMC: 2733237. DOI: 10.1089/apc.2008.0132. View

15.

Rumptz M, Tobias C, Rajabiun S, Bradford J, Cabral H, Young R . Factors associated with engaging socially marginalized HIV-positive persons in primary care. AIDS Patient Care STDS. 2007; 21 Suppl 1:S30-9. DOI: 10.1089/apc.2007.9989. View

16.

Bangsberg D . Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006; 43(7):939-41. DOI: 10.1086/507526. View

17.

Chesney M, Ickovics J, Hecht F, Sikipa G, Rabkin J . Adherence: a necessity for successful HIV combination therapy. AIDS. 2000; 13 Suppl A:S271-8. View

18.

Iacob S, Iacob D, Jugulete G . Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations. Front Pharmacol. 2017; 8:831. PMC: 5703840. DOI: 10.3389/fphar.2017.00831. View

19.

DiClemente C, Corno C, Graydon M, Wiprovnick A, Knoblach D . Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness. Psychol Addict Behav. 2017; 31(8):862-887. DOI: 10.1037/adb0000318. View

20.

Ware Jr J, Kosinski M, Keller S . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. DOI: 10.1097/00005650-199603000-00003. View